Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 72 holding rows worth $118,230,000.

Accession
0001389933-17-000018
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 72 entries on the cover page, a total value of $118,230,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $118,230,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LOXO ONCOLOGY INC548862101COM300,722$12,654,000thousands by filing date
ATRICURE INC04963C209COM506,946$9,708,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK216,119$5,798,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM221,013$4,597,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock541,128$4,545,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM867,529$3,557,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM82,500$3,299,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR35,359$3,048,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR81,231$2,974,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM411,000$2,836,000thousands by filing date
ARDELYX INC039697107COM221,738$2,805,000thousands by filing date
INSULET CORP COM45784P101Stock63,484$2,736,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM350,392$2,610,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH8,700$2,551,000thousands by filing date
INSULET CORP45784PAD3NOTE 2.000% 6/12,250,000$2,537,000thousands by filing dateprincipal
NEUROCRINE BIOSCIENCES INC64125C109COM58,508$2,533,000thousands by filing date
MACROGENICS INC556099109COM119,200$2,217,000thousands by filing date
BIOTELEMETRY INC090672106COM75,000$2,171,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM46,770$2,121,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,500,000$1,963,000thousands by filing dateprincipal
SPECTRANETICS CORP84760C107COM65,496$1,908,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW48,809$1,886,000thousands by filing date
CELLECTIS ADS15117K103COM76,404$1,834,000thousands by filing date
CARA THERAPEUTICS INC140755109COM95,322$1,753,000thousands by filing date
IMMUNOMEDICS INC452907108COM252,574$1,634,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock208,458$1,626,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS325,667$1,612,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK473,478$1,567,000thousands by filing date
ADVAXIS INC007624208COM NEW172,000$1,405,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock339,614$1,358,000thousands by filing date
UNIQURE NVN90064101SHS203,907$1,179,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,171,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock381,900$1,054,000thousands by filing date
NEURODERM LTDM74231107ORD SHS37,438$994,000thousands by filing date
BIOLINERX LTD-SPONS ADR09071M106SPON1,000,000$961,000thousands by filing date
DERMIRA INC24983L104COM28,000$955,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK71,320$944,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD85,947$907,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM724,286$869,000thousands by filing date
ARQULE INC04269E107COM807,008$855,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM196,500$827,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock101,317$821,000thousands by filing date
BLUEBIRD BIO INC09609G100COM9,000$818,000thousands by filing date
EXACTECH INC30064E109COM31,636$797,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,372,862$782,000thousands by filing date
CASCADIAN THERAPEUTICS INC14740B606COM NEW185,259$767,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM95,841$747,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333XAD0DBCV 2.250% 6/1573,000$714,000thousands by filing dateprincipal
NEOS THERAPEUTICS INC64052L106COM95,273$686,000thousands by filing date
ZOGENIX INC.98978L204Common Stock59,778$649,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK70,455$648,000thousands by filing date
COGENTIX MED INC COM19243A104Stock353,482$636,000thousands by filing date
GEMPHIRE THERAPEUTICS INC36870A108COM52,797$554,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR18,214$510,000thousands by filing date
Rocket Pharmaceuticals Inc45780V102SHS237,135$474,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM35,977$412,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM265,000$405,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM88,067$379,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/0600,000$372,000thousands by filing dateprincipal
ABEONA THERAPEUTICS INC00289Y107COM67,537$338,000thousands by filing date
CELYAD ONCOLOGY SA151205200ADR12,528$328,000thousands by filing date
MASIMO CORP COM574795100Stock3,500$326,000thousands by filing date
ObsEva SAH5861P103COM25,000$260,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM20,000$247,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock55,700$217,000thousands by filing date
AFFIMED N VN01045108COM92,500$213,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM53,525$139,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW30,000$128,000thousands by filing date
ANAPTYSBIO INC032724106COM4,500$125,000thousands by filing date
TONIX PHARMACEUTICALS HLDG C890260409COM20,000$93,000thousands by filing date
BIOPHARMX CORP09072X101COM115,000$58,000thousands by filing date
GALENA BIOPHARMA INC COM NEW363256504Stock46,145$28,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-17-000018this filing2017-05-15acceptance time not in the bulk data set